Targeting p53–MDM2 interaction by small-molecule inhibitors: Learning from MDM2 inhibitors in clinical trials

H Zhu, H Gao, Y Ji, Q Zhou, Z Du, L Tian… - Journal of hematology & …, 2022 - Springer
Abstract p53, encoded by the tumor suppressor gene TP53, is one of the most important
tumor suppressor factors in vivo and can be negatively regulated by MDM2 through p53 …

The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches

AC Joerger, AR Fersht - Annual review of biochemistry, 2016 - annualreviews.org
Inactivation of the transcription factor p53, through either direct mutation or aberrations in
one of its many regulatory pathways, is a hallmark of virtually every tumor. In recent years …

Advances in stereoconvergent catalysis from 2005 to 2015: transition-metal-mediated stereoablative reactions, dynamic kinetic resolutions, and dynamic kinetic …

V Bhat, ER Welin, X Guo, BM Stoltz - Chemical reviews, 2017 - ACS Publications
Stereoconvergent catalysis is an important subset of asymmetric synthesis that
encompasses stereoablative transformations, dynamic kinetic resolutions, and dynamic …

Catalytic enantioselective α-allylation of deconjugated butenolides with Aza-π-allylpalladium 1, 4-dipoles: access to optically pure 2-piperidones bearing an all-carbon …

SP Yuan, Q Bao, TJ Sun, JQ Zhao, ZH Wang… - Organic …, 2022 - ACS Publications
A palladium-catalyzed enantioselective α-allylation of deconjugated butenolides with aza-π-
allylpalladium 1, 4-diploes, in situ generated from palladium-mediated decarboxylation of …

Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells

GH Mansour, MA El-Magd, DH Mahfouz… - Bioorganic …, 2021 - Elsevier
There are current attempts to find a safe substitute or adjuvant for Sorafenib (Sorf), the
standard treatment for advanced hepatocellular carcinoma (HCC), as it triggers very harsh …

[HTML][HTML] Discovery of MDM2-p53 and MDM4-p53 protein-protein interactions small molecule dual inhibitors

M Espadinha, EA Lopes, V Marques, JD Amaral… - European Journal of …, 2022 - Elsevier
MDM2 and MDM4 are key negative regulators of p53, an important protein involved in
several cell processes (eg cell cycle and apoptosis). Not surprisingly, the p53 tumor …

Compounds and methods for the targeted degradation of androgen receptor

M Jin, AP Crew, H Dong, J Wang, X Chen… - US Patent …, 2022 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
56417710&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

Compounds and methods for the targeted degradation of bromodomain-containing proteins

Y Qian, H Dong, J Wang, M Berlin, AP Crew… - US Patent …, 2020 - Google Patents
US10772962B2 - Compounds and methods for the targeted degradation of bromodomain-containing
proteins - Google Patents US10772962B2 - Compounds and methods for the targeted …

The development of biologically important spirooxindoles as new antimicrobial agents

YT Yang, JF Zhu, G Liao, HJ Xu… - Current Medicinal …, 2018 - ingentaconnect.com
Background: Antibiotic resistance is one of the biggest threats to global health today, leading
to higher medical costs and increased mortality. Because of the emergence and rapid …

Reviving the guardian of the genome: Small molecule activators of p53

D Nguyen, W Liao, SX Zeng, H Lu - Pharmacology & therapeutics, 2017 - Elsevier
The tumor suppressor p53 is one of the most important proteins for protection of genomic
stability and cancer prevention. Cancers often inactivate it by either mutating its gene or …